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Abstract
This systematic review searched 4 databases (PubMed/MEDLINE, Scopus, CINAHL, and 
PsychINFO) and identified 21 articles eligible to evaluate the extent to which interventions that 
integrate depression care into outpatient obstetric practice are feasible, effective, acceptable, and 
sustainable. Despite limitations among the available studies including marked heterogeneity, there 
is evidence supporting feasibility, effectiveness, and acceptability. In general, this is an emerging 
field with promise that requires additional research. Critical to its real-world success will be 
consideration for practice workflow and logistics, and sustainability through novel reimbursement 
mechanisms.
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BACKGROUND
Depression occurring in pregnancy to within a year of delivery - perinatal depression - 
affects upwards of 1 in 7 women and is one of the most common pregnancy complications.1 
Perinatal depression is associated with negative maternal, obstetric, infant, and child 
outcomes.2–4 For example, maternal suicide exceeds hemorrhage and hypertensive disorders 
as an etiology of maternal mortality.1,5 While negative consequences can be ameliorated 
with evidence-based psychotherapy and/or psychopharmacologic treatment,6 perinatal 
depression is vastly under-diagnosed and under-treated.7
Given that detection is an important first step towards treatment, numerous professional 
organizations and policy makers recommend depression screening for pregnant and 
postpartum women using a validated tool.1,8,9 Screening is well accepted by women and 
providers,10,11 yet is a futile exercise when done in the absence of trained providers, mental 
health resources, and referrals.7 Barriers exist at the patient, provider, and systems-level that 
preclude women from getting needed mental health care.12–15 Without interventions in place 
to help obstetric practices respond appropriately to positive screens, less than 20% of women 
who screen positive initiate mental health care.7 Far fewer participate in adequate or 
sustained treatment.7 Identified barriers include: 1) inadequate/absent depression care 
training for obstetric providers; 2) lack of standardized processes for stepped depression 
care; 3) a dearth of mental health providers willing to treat pregnant and lactating women; 4) 
lack of referral resources; and, 5) inadequate care coordination and follow-up.16–20
Recognizing the prevalence of perinatal depression, its association with preventable 
morbidity and mortality, and barriers preventing appropriate recognition and treatment, the 
Council on Patient Safety in Women’s Health Care created a patient safety bundle for 
perinatal mood and anxiety disorders that provides direction for incorporating screening, 
intervention, referral, and follow-up across health care settings.8 Similarly, the American 
College of Obstetricians and Gynecologists, a significant and organizing partner in The 
Council, recommends screening in the context of systems ensuring effective diagnosis, 
treatment, and follow-up.1 The American Medical Association,21 U.S. Preventive Services 
Task Force,9 and Center for Medicare and Medicaid Services22 also recommend screening 
for depression in obstetric settings.
In response to these recommendations, efforts have been made to integrate depression care 
into obstetric practice. It is well-established that integrated care models, such as stepped and 
collaborative care, and medical homes, effectively integrate depression treatment into 
primary care settings and improve quality of mental health care and depression outcomes. 
Recognizing that such approaches hold promise for addressing gaps in perinatal depression 
care, interventions focused on helping obstetric practices screen, assess and treat depression 
have been developed and evaluated.7 The objective of this systematic review is to evaluate 
the extent to which interventions that integrate depression care into outpatient obstetric 
practice are feasible, effective, acceptable, and sustainable.
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METHODS
Database Search Strategy
This review was conducted using the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines.23 The study hypothesis was developed using the 
Population Intervention Comparison Outcome (PICO) method.24 A health sciences librarian 
(L.L.L.) iteratively developed the search strategies and conducted unique searches in 
PubMed/MEDLINE, Scopus, CINAHL, and PsychINFO in 2017. Major searched concepts 
included, but were not limited to pregnancy, prenatal care, postpartum period, peripartum 
period, postpartum depression, depression, maternal health services, obstetrics, delivery of 
integrated health care, collaborative care, and program evaluation. These major concepts 
were used to develop the initial PubMed search algorithm from which the strategies for other 
databases were created and modified based on differing command languages and where 
applicable, controlled vocabularies specific to the source (MeSH, CINAHL Subject 
Headings, the Thesaurus of Psychological Index Terms, and EMTREE). Additional free text 
terms were used as appropriate (Appendix 1). Recognized experts were queried, and 
bibliographic references were hand searched to identify additional studies.
Inclusion and Exclusion Criteria
Searches were limited to English language. Inclusion criteria were: 1) pregnant and/or 
postpartum (within 1 year of delivery) women as subjects; 2) non-adolescent focused 
populations (i.e., ≥18 years); 3) outpatient perinatal care setting with obstetric providers 
including obstetricians, family medicine and general practitioners, or midwives; 4) 
description of an intervention coordinating care between obstetric and mental health 
providers, and 5) at least one of four key outcomes, described below (Table 1). In addition to 
randomized controlled trials (RCTs), observational and quality improvement study designs 
were included to assess the range of evidence currently available. Exclusion criteria 
consisted of: 1) non-original research (e.g.; review article, meta-analysis, opinion, letter, 
case report, case series, or commentary), and 2) non-peer-reviewed articles.
Study Selection and Abstractions
After duplicates were removed, all authors screened citations/abstracts derived from the 
initial literature search. Initial abstraction information was collected using Rayyan, a 
systematic review web application maintained by the Qatar Foundation and Qatar 
Computing Research Institute.25 The citations/abstracts were equally divided with at least 
two abstractors independently reviewing each set of citations/abstracts for eligibility. 
Articles for which there was discordance resulted in review by the full team until 100% 
concordance was reached.
Studies that met all eligibility criteria were further abstracted and assessed using a 
standardized data abstraction form. The comprehensive abstraction form was created in 
REDCap,26 a web-based data capture application, and included the following study 
categories: research question, design, sample size, inclusion/exclusion criteria, setting, 
population, intervention, outcomes and conclusions.
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Definition of Intervention and Outcomes
Integrated care interventions were operationalized into eleven components (Table 1). The 
five components of collaborative care were examined: evidence-based care, population-
based care, measurement-based treatment to target, patient-centered team care, and 
accountable care.27
We included four outcomes of interest in our review (Table 1). Feasibility of implementing 
integrated care in the outpatient obstetric setting was evaluated by evidence of screening for 
depression using a validated tool, subsequent assessment to confirm a depression diagnosis, 
and referral for treatment which included yet was not limited to psychoeducation, 
psychotherapy, and psychopharmacology. Integrated care effectiveness was evaluated by 
evidence of treatment initiation, treatment sustainment, symptom improvement, and other 
maternal and birth outcomes. The acceptability of integrating mental health care into 
perinatal care was evaluated by evidence of patient, provider, staff, and practice satisfaction, 
efficacy, and/or utilization. Evidence of intervention sustainability was evaluated through 
costs and use of other resources.
Study Quality Assessment
Methodologic quality including validity, bias, power, and other study parameters was 
assessed using a modified Downs and Black checklist.28 The original checklist was designed 
for RCTs with a maximum quality rating score of 32 based on 27 items, eight of which are 
specific to RCTs.28 As recommended in prior methodologic reviews,29 and as we have done 
previously,7,30,31 we modified the original scale28 and excluded items that were not relevant 
to the specific design of each eligible study (Appendix 2). A percentage quality score was 
calculated by dividing the total score received by the maximum total score possible, with 
higher overall scores indicating better methodologic quality. The multi-component item 
regarding sample size and power was dichotomized into whether the study reported a priori 
sample size and power calculations or not.
Synthesis of Included Studies and Analyses
Data was synthesized, and commonalities were identified on the interventions and outcomes 
examining the integration of perinatal depression care in obstetric settings. Given the 
considerable heterogeneity between program descriptions and outcomes, a meta-analysis 
was not conducted.
RESULTS
The literature search yielded 1,115 articles with an additional 87 records identified through 
hand-searching and other means (Figure 1). After eliminating duplicates, a total of 1,069 
references were identified with 1,022 removed after citation/abstract review for not meeting 
inclusion criteria, leaving 47 articles for full-text review. After full-text review, 26 were 
removed because they did not meet pre-defined inclusion criteria. We completed full 
abstraction on 21 articles. Some interventions were reported on in more than one article 
including the Perinatal Mental Health (PMH) model,32–34 the Massachusetts Child 
Psychiatry Access Program (MCPAP) for Moms,35,36 the PRogram In Support of Moms 
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(PRISM),36,37 Healthy Outcomes of Pregnancy Education (DC-HOPE),38,39 and the 
Perinatal Depression Management Program (PDMP);40,41 thus, this review includes 21 
articles reporting on 15 unique integrated care models for addressing perinatal depression 
(Table 2).
A variety of study designs were employed including feasibility/pilot studies (n=5),
34,37,40,42,43
 quality improvement initiatives (n=2),44,45 retrospective cohort (n=2),46,47 
prospective cohort (n=7),32,33,35,41,48–50 and randomized controlled trials (n=5)36,38,39,51,52 
with randomization at the level of the patient (n=4)38,39,51,52 or practice (n= 1).36 Quality 
rating, based on the modified Downs and Black criteria, ranged from 21% to 100%; the 
average score was 68%. In general, quality ratings were lowered for RCTs and cohort 
studies due to not reporting actual probability values (50%), poor reporting on the 
distributions of principal confounders (71%), and/or inadequate adjustment for confounding 
in the analyses (93%).
Most studies (n=18) took place in the United States;32–43,45,46,49–52 international studies 
included one each from Australia,44 Canada,47 and South Africa.48 Sample size ranged from 
30 to 7,630 overall, and 30 to 1,044 in the RCTs36,38,39,51,52 (Table 2). More than half of the 
studies did not include a comparison group (n=11);32–35,37,42,45,47–50 those with comparison 
groups (n=10) consisted of pre-intervention or historical controls,40,41,44 usual care,
38,39,43,46,51,52
 or active intervention.36 Several studies noted intervening to benefit specific 
populations including Hispanic,32,34,40,41 African American,38,39 and socioeconomically 
disadvantaged34,40,48,51,52 women, as well as women veterans.45
All studies included more than one integrated care intervention component. The majority of 
studies (57%) included ≥8 integrated care components as part of their described intervention 
(mean=7, range=2–10) (Figure 2, Table 3). Nearly all studies included systematic provision 
of resources to patients (n=20)32–37,39–52 and on-site face to face assessment (n=19).
32–37,40–52
 While twelve (57%) studies self-reported implementation of collaborative care,
32–34,40,41,45–48,50–52
 only one46 included the five collaborative care components. Among all 
studies, the collaborative care intervention components were utilized by most: evidence-
based care (n=16),32–34,38–46,48,50–52 population-based care (n=14),32–34,36,40,41,45–52 
measurement-based treatment to target (n=12),32–34,40,41,45–50,52 and patient-centered team 
care (n=11).32–34,40,41,45,46,48,50–52 Only one study included accountable care.46
Feasibility
All studies implemented screening using one of three validated screening instruments 
(Figure 3); the Edinburgh Postnatal Depression Scale (EPDS) cut-offs scores ranged from 9–
13. Thirteen studies (62%) assessed depression following a positive screen using a variety of 
approaches. Depression diagnosis following assessment after positive screen ranged from 
19–65%.32,41,45,49 Among all studies, reported mental health services referral rates for 
patients identified with non-emergency needs ranged from 11–100%.32–35,40–43,46–48,50 
Miller et al. reported rates of clinician performed interviews after positive screens increased 
from 10% pre-intervention to 85% during the intervention; clinicians in this study were 
family physicians and midwives at a federally qualified health center.41 Wood et al. reported 
that all patients who screened positive were offered referral to a family physician or mental 
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health therapist with approximately half (46.7%) accepting referral.47 Byatt et al. reported 
that telephone consultation with providers in MCPAP for Moms resulted in a variety of 
outcomes.35 In the majority of calls, the calling provider continued to manage the patient 
(78%), which was followed by referral for therapy (38%), care coordination (36%), referral 
to a new psychiatrist (18%) and other dispositions including referral to emergency services 
(1%).35 Venkatesh et al. reported that 79% of screen positive patients were referred for 
mental health treatment.50
Effectiveness
Fifteen studies32,33,38,39,41–51 reported evidence of treatment initiation with rates ranging 
from 12–98% (Figure 3). Few studies (n = 5)32,46,47,51,52 reported evidence of treatment 
sustainment with an overall range of 55–100% (Figure 3). Baker-Ericzen et al. reported that 
55% of subjects completed the treatment plan.32 Grote et al. reported that 93% and 84% 
respectively completed ≥4 and ≥8 interpersonal psychotherapy or medication management 
sessions, and 79% had ≥1maintenance session through 18-month follow-up.51 Katon et al. 
reported that 74% and 81% of patients with commercial and no/public insurance 
respectively attended ≥4 mental health visits.52 Truitt et al. reported that their collaborative 
care group had a mean of 13 mental health related visits, and that 100% had ≥3 follow-up 
contacts.46 Wood et al. reported that 41% withdrew before their therapist considered 
treatment complete, thus indicating that 59% had complete treatment.47
Few studies (n=4) assessed effectiveness of symptom improvement over time36,44,51,52 
and/or symptom remission,46,51 and those that did used differing approaches with varying 
results that all indicated improvement even in the context of small sample sizes. For 
example, Byatt et al. reported statistically significant declines over time in mean EPDS 
scores and EPDS scores ≥10 in both study groups (n=30).36 Truitt et al. reported that 46.7% 
of subjects in the collaborative care group (n=15) experienced clinical remission as 
compared to 6.3% receiving routine care (n=63, p <0.01).46 There was very limited data on 
other depression-related outcomes; Rowan et al. noted that there were no tragic outcomes 
including maternal suicide or newborn neglect.42 No studies reported on additional maternal 
or child outcomes, such as preterm birth, low birth weight neonate, or others (Figure 3).
Acceptability
Ten studies reported patient satisfaction, although the metrics were highly variable, spanning 
both qualitative and quantitative data, and often limited to a subset of study participants.
32–34,36,39,40,42,43,51,52
 All studies reported that the majority of women were accepting of the 
various interventions and had positive experiences. Representative examples of patient 
satisfaction included that women felt comfortable talking about mood and/or found 
discussions supportive,33,36,43 patients were satisfied with or felt positively about 
intervention staff and/or found them helpful32–34,39,43 and were satisfied with care and/or 
the intervention33,43,51,52 (Figure 3).
Evidence of intervention acceptability to providers was reported in 7 studies.33,35–37,40,43,49 
Examples included improved provider self-efficacy was reported with increased certainty in 
ability to effectively treat perinatal depression,36 increased use of validated screening tools,
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33
 high rates of provider-initiated depression discussions after notice of a positive screen,49 
and increased referral to community resources33 (Figure 3). Considering utilization as 
evidence of provider acceptability, the MCPAP for Moms program enrolled 100 obstetric 
practices, trained 350 obstetric providers, and served 1,123 women in the first 18 months.35
Acceptability was reported in 6 studies33,35–37,43,47 with representative examples including 
staff demonstrating improvement in the knowledge and skills to address perinatal 
depression,36 increased screening and use of validated screening tools,33,37 familiarity with 
programs,33,36 and high intervention utilization35 (Figure 3). One study noted varying levels 
of support and interest among providers and staff with several office practice providers 
refusing to participate due to concerns over productivity targets and extra time needed for 
intervention.46 Another study reported that space, scheduling issues, wait times, and staff 
support negatively affected implementation.43
Sustainability
Only 3 studies (14%) provided any results regarding the costs of their integrated 
interventions.35,44,51 Two studies35,51 provided a per woman cost that ranged widely. Based 
on a total program operating cost for the Massachusetts state-wide program MCPAP for 
Moms of $600,000 for ~72,000 deliveries/year, Byatt et al. calculated the cost at $8.38 per 
perinatal woman per year ($0.70/month) and noted that there were additional start-up 
administrative expenses and community capacity building.35 Utilizing $80 per depression 
care specialist visit and $31 per phone visit, Grote et al. estimated the per patient cost at 
$1,117.51 Harvey et al. did not provide a cost per patient; however, it was noted that the 
program funded a senior level-experienced mental health nurse position (1.4 FTE) and an 
administrative staff person (0.6 FTE).44
DISCUSSION
Gaps in perinatal depression care persist because getting pregnant or postpartum women 
needed mental health care is a complex process hindered by patient, provider and systems-
level barriers.12–15 As a result, clinical resolution of depression symptoms is uncommon in 
obstetric settings.11 Known barriers to perinatal depression treatment include lack of 
standardized processes for depression care in obstetric settings,19,20 inadequate referral 
resources,16–20 and inadequate care coordination and follow-up.16–20 While the existing 
evidence is limited in both the total number of studies and study participants, interventions 
presented, and outcomes evaluated, our review suggests that integrating depression care into 
obstetric practice is feasible, effective, and acceptable.
Although all the included studies focused on adult pregnant and postpartum women 
receiving care in outpatient obstetric settings, described an intervention coordinating 
obstetric and mental health care, and evaluated feasibility, effectiveness, acceptability, and/or 
sustainability, there existed substantial heterogeneity. Studies differed regarding: 1) 
intervention components deployed, 2) specifics of outcomes and outcome assessments, and 
3) study design. Aligned with the Agency for Healthcare Research Quality’s 
recommendations, future research would benefit from consensus on core measures that are 
standardly reported and compared across studies.53 The heterogeneity of the current studies 
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made it challenging to evaluate which of the 11 integrated care components was associated 
with greatest improvements in outcomes. Multi-component interventions were common and 
associated with feasibility, effectiveness, and acceptability (Table 3, Figure 3). This is 
consistent with a previous systematic review by Byatt et al. which found that intervention 
type and intensity is associated with differential engagement in mental health care for 
pregnant and postpartum women with depression.7 More research utilizing standardized 
definitions and outcomes is needed to more completely understand the potential and promise 
of integrating mental health and obstetric care, and to discern which components are most 
impactful.
The sustainability of these interventions is largely unknown. Only three included articles 
directly addressed financial and resource expenditures of integrated care interventions35,44,51 
and the two that provided per woman costs ranged broadly from $8.3835 to $1,117.51
Despite treatment success, collaborative care models depend on care management facets that 
are not reliably reimbursed and therefore their broad implementation, dissemination, and 
associated treatment improvement are often not realized outside of the research environment.
54
 The term “voltage drop” has been used to describe the less robust results found when 
collaborative care approaches are implemented in low resource real-world settings.55 
Recognizing the effectiveness of and improved outcomes of integrating mental health 
services within primary care, while acknowledging limited uptake given the absence of clear 
business models for incorporating these services into practice, the Center for Medicare and 
Medicaid Services has recently begun paying clinicians separately for mental health services 
provided to Medicare beneficiaries.56 Although relatively few perinatal women are Medicare 
beneficiaries, these types of changed financial compensation systems, including value-based 
and outcomes-based incentive programs, offer hope for the future reimbursement and thus 
sustainability of such interventions.
Health care reform presents unprecedented opportunities to design and test new integrated 
care models and unique service delivery models that leverage limited mental health 
providers and resources. Thus, it is important to consider the full breadth of integrated care 
interventions. Hence, our systematic review focused not on just collaborative care as the 
gold-standard, but rather we expanded our scope to include an array of integrated care 
interventions with the potential for lower cost such as MCPAP for Moms ($8.38/woman)35 
contrasted with standard collaborative care ($1,117/woman).51 Of note, healthcare provider 
feedback loop and accountable care were the two integrated care components utilized by the 
least number of included studies (Figure 2, Table 3) and yet are likely critical when 
considering value-based care payment models.
Our review was limited by the available studies. First, heterogeneity among the studies 
precluded meta-analysis. Many of the included studies were not randomized controlled 
trials. Overall study quality was low, averaging 68%. It is notable that those with the highest 
scores were of less robust study designs and thus not eligible for full points utilizing the 
modified Downs and Black checklist. The 5 randomized controlled trials quality scores 
ranged from 33–63%. Finally, as the studies varied widely in interventions and outcomes, 
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generalization is difficult. Further research is needed to understand how to delineate 
essential components and optimize its impact and sustainability.
Despite limitations among the available studies, there is evidence to support the feasibility, 
effectiveness, and acceptability of integrating mental health and obstetric care for pregnant 
and postpartum women in ambulatory obstetric settings. The included studies demonstrated 
feasibility of screening with validated tools, of performing a subsequent diagnostic 
assessment, and referring women to mental health care. Studies demonstrated effectiveness 
via treatment initiation, and in some cases treatment sustainment and efficacy via symptom 
improvement and remission. Interventions were overall acceptable to patients, providers, and 
practice staff.
In general, integrating mental health care into obstetric settings is an emerging field with 
promise that requires additional research. Critical to its real-world success will be adoption 
with consideration for practice workflow and logistics, and sustainability through novel 
reimbursement mechanisms. However, given that untreated perinatal depression is estimated 
to cost ~$22,000 per maternal-child dyad,57 is one of the most common pregnancy 
complications,1 and is associated with negative maternal, obstetric, infant, and child 
outcomes2–4 including high health care utilization,58,59 there is reason to hypothesize that if 
effective, integrated care interventions can result in long-term cost-savings for the health 
care system and improved intergenerational maternal-child outcomes.
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Appendix 1. Database Search Methods
PubMed
(((("Pregnancy"[Mesh] OR "Postpartum Period"[Mesh] OR "Peripartum Period"[Mesh] OR 
"Pregnancy Trimesters"[Mesh] OR "Depression, Postpartum"[Mesh] OR ("depression"[All 
Fields] AND "postpartum"[All Fields]) OR "postpartum depression"[All Fields] OR 
"depression, postpartum"[All Fields]) AND ("Maternal Health Services"[Mesh] OR 
"Obstetrics"[Mesh]) AND ("Delivery of Health Care, Integrated"[Mesh] OR 
"Comprehensive Health Care"[Mesh] OR ("collaborative care"[All Fields] OR 
collaborate[tiab] OR collaborated[tiab] OR collaborates[tiab] OR collaborating[tiab] OR 
collaboration[tiab] OR collaborational[tiab] OR collaborationist[tiab] OR 
collaborationists[tiab] OR collaborations[tiab] OR collaborative[tiab] OR 
collaboratively[tiab] OR collaborativeness[tiab] OR collaboratives[tiab] OR 
collaborator[tiab] OR collaborator'[tiab] OR collaboratories[tiab] OR collaborators[tiab] OR 
collaboratory[tiab])) AND ("Feasibility Studies"[Mesh] OR "Patient Acceptance of Health 
Care"[Mesh] OR "Treatment Outcome"[Mesh] OR "Program Evaluation"[Mesh])) NOT 
(Case Reports[ptyp] OR Letter[ptyp] OR Comment[sb] OR commentary[ti] OR opinion[ti] 
OR Meta-Analysis[ptyp])) AND English[lang]) Filters: English
SCOPUS
(TITLE-ABS-KEY (pregnancy OR "Postpartum Period" OR "Peripartum Period" OR 
"Pregnancy Trimesters" OR "Depression, Postpartum" OR ("depression" AND 
"postpartum") OR "postpartum depression" OR "depression, postpartum")) AND (TITLE-
ABS-KEY ("Feasibility Studies" OR "Patient Acceptance of Health Care" OR "Treatment 
Outcome" OR "Program Evaluation")) AND ((TITLE-ABS-KEY ("Delivery of Health 
Care,Integrated" OR "Comprehensive Health Care" OR ("collaborative care" OR collaborate 
OR collaborated OR collaborates OR collaborating OR collaboration OR collaborational OR 
collaborationist OR collaborationists OR collaborations))) OR (TITLE-ABS-KEY 
((collaborationship OR collaborative OR collaboratively OR collaborativeness OR 
collaboratives OR collaborator OR collaborators)))) AND (LIMIT-TO (DOCTYPE, "ar") 
OR LIMIT-TO (DOCTYPE, "cp")) AND (LIMIT-TO (LANGUAGE, "English"))
CINAHL
((MH “Pregnancy”) OR (MH “Postnatal Period”) OR (MH “Pregnancy Trimesters”) OR 
(MH “Depression, Postpartum”) OR (MH “Depression”) OR “peripartum period”) AND 
((MH “Maternal Health Services”) OR (MH “Obstetrics”)) AND ((MH “Health Care 
Delivery, Integrated”) OR (“comprehensive health care”) OR (“collaborative care”) AND 
((MH “Pilot Studies”) OR (“patient acceptance”) OR (MH “Program Evaluation”) OR 
((“MH “Treatment Outcomes”) OR (MH “Outcome Assessment”))
PsycINFO
(exp Pregnancy OR (exp Postnatal Period/ OR exp Major Depression/ OR exp Postpartum 
Depression)) AND ((exp Health Care Services/ OR maternal health services.mp) OR exp 
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Obstetrics) AND ((exp Integrated Services/ OR comprehensive care.mp OR (exp 
Collaboration/ OR collaborative care.mp)) AND (exp Treatment Outcomes/ OR patient 
acceptance.mp OR exp Program Evaluation/)
Appendix 2. Modified Downs & Black Criteria for Quality Scoring
RCT Prospective
Observational
Retrospective
Observational
Pilot Feasibility Quality
Improvement
1. Is the hypothesis/aim/
objective of the study clearly 
described?
✓ ✓ ✓ ✓ ✓ ✓
2. Are the main outcomes to be 
measured clearly described in 
the Introduction or Methods 
section?
✓ ✓ ✓ ✓ ✓ ✓
3. Are the characteristics of the 
patients included in the study 
clearly described?
✓ ✓ ✓ ✓ ✓ ✓
4. Are the interventions of 
interest clearly described?
✓ ✓ ✓ ✓ ✓ ✓
5. Are the distributions of 
principal confounders in each 
group of subjects to be 
compared clearly described?
✓ ✓ ✓
6. Are the main findings of the 
study clearly described?
✓ ✓ ✓ ✓ ✓ ✓
7. Does the study provide 
estimates of the random 
variability in the data for the 
main outcomes?
✓ ✓ ✓
8. Have all important adverse 
events that may be a 
consequence of the intervention 
been reported?
✓
9. Have the characteristics of 
patients lost to follow-up been 
described?
✓
10. Have actual probability 
values been reported?
✓ ✓ ✓
11. Were the subjects asked to 
participate in the study 
representative of the entire 
population from which they 
were recruited?
✓ ✓
12. Were those subjects who 
were prepared to participate 
representative of the entire 
population from which they 
were recruited?
✓ ✓
13. Were the staff, places, and 
facilities where the patients 
were treated, representative of 
the treatment the majority of 
patients receive?
✓ ✓
14. Was an attempt made to 
blind study subjects to the 
intervention they have received?
✓
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RCT Prospective
Observational
Retrospective
Observational
Pilot Feasibility Quality
Improvement
15. Was an attempt made to 
blind those measuring the main 
outcomes of the intervention?
✓
16. If any of the results of the 
study were based on “data 
dredging”, was this made clear?
✓ ✓ ✓
17. In trials and cohort studies, 
do the analyses adjust for 
different lengths of follow-up of 
patients, or in case-control 
studies, is the time period 
between the intervention and 
outcome the same for cases and 
controls?
✓ ✓ ✓
18. Were the statistical tests 
used to assess the main 
outcomes appropriate?
✓ ✓ ✓ ✓
19. Was compliance with the 
intervention/s reliable?
✓
20. Were the main outcome 
measures used accurate (valid 
and reliable)?
✓ ✓ ✓ ✓
21. Were the patients in 
different intervention groups 
(trials and cohort studies) or 
were the cases and controls 
(case-control studies) recruited 
from the same population?
✓ ✓ ✓ ✓
22. Were study subjects in 
different intervention groups 
(trials and cohort studies) or 
were the cases and controls 
(case-control studies) recruited 
over the same period of time?
✓ ✓ ✓ ✓
23. Were study subjects 
randomised to intervention 
groups?
✓
24. Was the randomised 
intervention assignment 
concealed from both patients 
and health care staff until 
recruitment was complete and 
irrevocable?
✓
25. Was there adequate 
adjustment for confounding in 
the analyses from which the 
main findings were drawn?
✓ ✓ ✓
26. Were losses of patients to 
follow-up taken into account?
✓ ✓ ✓
27. Did the study report a priori 
power analysis?
✓ ✓ ✓
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Figure 1. Article Selection Process
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Figure 2. Numbers and Percentages of Studies Containing Each Integrated Care Intervention 
Component
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Figure 3. Outcome Results of the 21 Studies Included in the Systematic Review of Integrating 
Depression Care for Pregnant and Postpartum Adult Women in Obstetric Settings
For Sustainability as indicated by (*), representative examples are included. Abbreviations: 
BDI, Beck Depression Inventory; EPDS, Edinburgh Postnatal Depression Scale; DASS, 
Depression Anxiety Stress Scales; FTE, full-time equivalent; IPT, interpersonal 
psychotherapy; LCSW, licensed clinical social worker; MINI, Mini International 
Neuropsychiatric Interview; PHQ-9, Patient Health Questionnaire; ref, reference; SCID, 
Structured Clinical Interview for Diagnosis; SCL-20, Symptom Checklist Depression Scale
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Table 1
Outcome Questions and Integrated Care Intervention Component Definitions
Outcome Questions
Feasibility Was depression screening performed using a validated tool?
Was an assessment performed to confirm the diagnosis of 
depression?
Was a referral for depression treatment made?
Effectiveness Was depression treatment initiated?
Was depression treatment sustained?
Was there evidence of improved symptoms?
Were any other obstetric or maternal-child outcomes improved?
Acceptability Were patients satisfied with the intervention?
Were provider and/or practice satisfaction, efficacy, and/or 
utilization measured?
Sustainability Were costs of intervention measured?
Were other resources measured?
Integrated Care Intervention 
Component Definitions
Patient-centered team care Health providers collaborate effectively using shared care plans 
that incorporate patient goals.
Measurement-based treatment to 
target
Treatment plan clearly articulates personal goals and clinical 
outcomes that are routinely measured by evidence-based tools. 
Treatments are actively changed if patients not improving as 
expected until goals are achieved.
Evidence-based care Patients are offered evidence-based treatments of target condition.
Accountable care Providers are accountable and reimbursed for quality of care and 
clinical outcomes, not just the volume.
Co-located behavioral health Mental health evaluation and/or treatment by a mental health 
provider on-site within obstetric setting
On-site face-to-face assessment with 
patient by obstetric team
Mental health care assessment by an on-site case manager, social 
worker, or perinatal care provider (e.g., obstetrician or midwife) in 
the perinatal care setting
Access to mental health consultation Mental health consultation with either perinatal or general 
psychiatrist made available to provider and/or patient either via 
face-to-face, virtual face-to-face (telepsychiatry), telephone, or on-
line (e.g., email)
Systematic provision of resources to 
patients
Perinatal care team or research team provides mental health 
resources or referrals to depressed women.
Population-based care Care team shares a defined group of patients tracked/followed in a 
registry to ensure no one falls through the cracks.
Healthcare provider feedback loop Provided feedback to health care providers on their screening, 
treatment rates, or both
Psychoeducation or treatment 
engagement strategies
Perinatal care or research team discusses screening results or 
resources for treatment, provides educational material about 
perinatal depression, or use of tools to facilitate depression 
discussion in the perinatal care setting.
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Table 2
Characteristics of the 21 Studies Included in the Systematic Review of Integrating Depression Care for 
Pregnant and Postpartum Adult Women in Obstetric Settings
Author,
Year
Study Type, Provider 
Setting,
and Geography
Sample Size,
Comparison Groups
Intervention Quality
Score*
Baker-
Ericzen et al., 
2008
Prospective Cohort; 3 OB, 
3 pedi practices (17 
providers, 40 staff); 
California, USA
n=718 pp; no comparison 
group
PWH and the 4As; screening in clinical 
setting; practice referral of positive screen 
to MHA; MHA telephonically assesses and 
provides direct support and referral to 
existing treatment resources
42% (8/19)
Baker-
Ericzen et al., 
2012
Prospective Cohort 
embedded in RCT; 10 OB 
practices; California, USA
n=79 preg or pp (up to 6 wks); 
no comparison group
PMH and the 4As; screening in clinical 
setting; practice referral of positive screen 
to bilingual, bicultural MHA; MHA 
telephonically assesses and provides direct 
support, psychoeducation, and referral to 
existing treatment resources
53% (10/19)
Baron et al., 
2015
Prospective Cohort; 1 
OB/MW practice; Cape 
Town, South Africa
n=3,311 preg; no comparison 
group
Screening in clinical setting; referral to free 
on-site individual counselor (psychiatrist if 
severe)
79% (15/19)
Byatt et al., 
2016
Prospective Cohort; 100 
OB practices (47% of state, 
350 providers, 2,583 LIPs); 
Massachusetts, USA
n=1,123 preg and pp; no 
comparison group
MCPAP for Moms program with 1) 
trainings and toolkits, 2) perinatal 
psychiatric consultation via phone for 
providers, and 3) care coordination to link 
women with individual psychotherapy and 
support groups
21% (4/19)
Byatt et al., 
2016
Feasibility; 1 OB practice 
(14 providers); 
Massachusetts, USA
n=50 preg and pp; no 
comparison group
PRISM program leverages OB providers 
and staff to detect, assess, refer, and treat; 
program components: 1) trainings and 
toolkits, 2) systematic screening, and 3) 
perinatal psychiatric consultation via phone 
for providers
40% (2/5)
Byatt et al., 
2017
Pilot cluster RCT (practice-
level randomization); 4 OB 
practices (32 providers, 39 
staff); Massachusetts, USA
n=30 preg and pp; n=9 
MCPAP for Moms alone; 
n=21 PRISM
Active comparison group: MCPAP for 
Moms (Byatt et al. 2016); Intervention 
group: PRISM (MCPAP for Moms plus 
practice level implementation with 
additional training, toolkits, technical 
assistance, and change management)
63% (17/27)
Connelly et 
al., 2010
Feasibility study; 2 OB 
practices; California, USA
n=50 preg and pp; no 
comparison group
PMH and the 4As; screening in clinical 
setting; practice referral of positive screen 
to bilingual, bicultural MHA; MHA 
telephonically assesses and provides direct 
support, psychoeducation, and referral to 
existing treatment resources
100% (5/5)
Flynn et al., 
2006
Prospective Cohort; 1 OB 
practice (4 OB/GYNs, 2 
NPs); Michigan, USA
n=1,298 preg; no comparison 
group
Treating physician notified, nurse-delivered 
depression feedback, education and referral 
information (based on patient preference, 
insurance status, geography); primary 
referral to on-site MH SW for 
psychotherapy vs. psychiatry referral
89% (17/19)
Grote et al., 
2015
Multisite RCT (patient-
level blinding and 
randomization); 10 public 
health centers; Oregon, 
USA
n=168 preg women 
randomized (83 MOMCare, 
85 MSS-Plus/Usual care 
control)
Usual care control: MSS-Plus 
(multidisciplinary team including SW, 
nurses, and nutritionists); Intervention: 
MSS-Plus and MOMCare collaborative 
care, evidence-based depression care, 
systematic outreach, measurement, and 
stepped care with access to IPT and 
pharmacotherapy; delivered by depression 
care specialist, psychiatrist, and 
psychologist
52% (14/27)
Harvey et al., 
2012
Quality improvement; 
general practitioners, 
tertiary hospital-based 
n=783 preg-2 yrs pp (n=455 
preg, n=328 pp); comparison 
group = pre-intervention
Nurse-led consultation liaison model 
supporting general primary providers; 
initial call and 1–3 face-to-face 
100% (5/5)
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Author,
Year
Study Type, Provider 
Setting,
and Geography
Sample Size,
Comparison Groups
Intervention Quality
Score*
outpatient clinics; 
Queensland, Australia
appointments including assessment, brief 
intervention, community link, and referral 
strategies; healthcare provider training, 
case management, on-site assessment, 
resources, referral, follow-up
Joseph et al., 
2009
RCT (patient-level 
randomization); 6 OB 
practices; Washington, 
District of Columbia, USA
n=1,044 (Intervention n=521; 
Usual care n=523)
Clinic-based integrated intervention 
delivered during 8 routine prenatal care 
sessions (≥4 ‘adequate’); adapted group 
CBT for depression; pregnancy advisors 
work with participants to develop 
intersession homework
48% (13/27)
Katon et al., 
2015
RCT (patient-level 
randomization); 2 OB 
practices; Washington, 
USA
n=205 preg and pp; 
Intervention vs. Usual care
Intervention: Collaborative care program, 
care manager engagement session, 
psychotherapy vs. med treatment choice 
(charity med programs), proactive outreach, 
in-person vs. phone visits, education, and 
SW; regular contact over 12 mos; tracked 
and reviewed with care manager, psych, 
and OB/GYN; Usual Care: education 
pamphlet and opportunity for referral to 
social work or psych consult
41% (11/27)
Katon et al., 
2017
Quality improvement; 1 VA 
Medical Center and 10 
Community Clinics; 
Western Region, USA
n=199 preg or <8 wks pp; no 
comparison group
Systematic screen 3 times in perinatal 
period; dedicated maternity care 
coordinator, on-site LCSW and OB/GYN
100 (5/5)
Katz et al., 
2008
RCT (patient-level 
randomization); 6 OB 
practices; Washington, 
District of Columbia, USA
n=1,044 (Intervention n=521; 
Usual care n=523); <28 wks 
preg
Clinic-based integrated intervention 
delivered during 8 routine prenatal care 
sessions (≥4 ‘adequate’); adapted group 
CBT for depression; pregnancy advisors 
work with participants to develop 
intersession homework
33% (9/27)
Miller et al., 
2009
Pilot study; 1 urban family 
health center (4 family 
physicians, 4 MWs, 2 OB/
GYNs, 2 pediatricians, 1 
internist, 1 NP, and 1 SW); 
Illinois, USA
n=7,630 preg and pp; 
intervention group: n=2,191; 
pre-intervention group: 
n=5,439
PDMP: Screening, provider assessment, 
algorithm to guide decisions, evidence-
based pharmacotherapy guidelines, phone 
support, web-based consultation, feedback 
loop
78% (7/9)
Miller et al., 
2012
Prospective Cohort; 1 
federally qualified health 
center (family physicians 
and MW); Illinois, USA
n=541 preg and pp; 
intervention group: n=400; 
historical control comparison: 
n=141
PDMP; Intervention group: referral, 
healthcare provider training, case 
management, on-site assessment, resources, 
telephonic MH consultation, feedback loop, 
engagement strategies; pre-intervention 
group: on-site assessment
74% (14/19)
Rowan et al., 
2012
Feasibility study; 1 large 
multi-specialty medical 
organization, 19 
participating OB clinics (29 
OB/GYNs); Texas, USA
n=2,199 preg and pp; n=569 
with data at 6 wks pp; no 
comparison group
Screening in clinical setting; engagement 
strategies (EPDS ≥9); resources, referral, 
and systematic follow-up (EPDS≥14)
100% (5/5)
Scholle et al., 
2003
Feasibility study; 3 OB 
practices (11 OB/GYNs, 1 
NP, multiple OB residents); 
Pennsylvania, USA
n=891 preg & pp (different 
clinic settings); compared to 
unexposed clinics
Screening in clinical setting, on-site 
assessment (most by phone), referral 
evaluation; case management; engagement 
strategies
100% (5/5)
Truitt et al., 
2013
Retrospective Cohort; 5 
primary care facilities; 
Minnesota, USA
n=78 pp (within 1 yr); n=15 
Collaborative care; n=63 
Usual care
Screening in clinical setting, referral for 
MH evaluation and treatment as either part 
of collaborative care management program 
or routine PPD care, treatment follow-up 
and remission
88% (15/17)
Venkatesh et 
al., 2016
Prospective Cohort; 3 OB 
practices; Massachusetts, 
USA
n=576 preg and pp (n=396 
preg. n=180 pp); no 
comparison group
Screening in clinical setting, referral by on-
site LCSW for MH evaluation, treatment 
initiation
63% (12/19)
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Author,
Year
Study Type, Provider 
Setting,
and Geography
Sample Size,
Comparison Groups
Intervention Quality
Score*
Wood et al., 
2010
Retrospective Cohort; 7 
public health centers and 1 
community MH clinic; 
Alberta, Canada
n=100 pp; no comparison 
group
Screening in clinical setting, referral to 
PPD consultation service, treatment 
initiation and follow-up
71% (12/17)
4 As, Assess, Advise, Assist, Arrange; CBT, cognitive behavioral therapy; EPDS, Edinburgh Postnatal Depression Scale; IPT, interpersonal 
psychotherapy; LCSW, licensed clinical social worker; LIP, licensed independent practitioner; MCPAP, Massachusetts Child Psychiatry Access 
Program; MH, mental health; MHA, mental health advisor; mo, month; MSS-Plus, Maternity Support Services; MW, midwife; NP, nurse 
practitioner; OB, obstetric; OB/GYN, obstetrician-gynecologist; PDMP, Perinatal Depression Management Program; pedi, pediatric; PMH, 
Perinatal Mental Health model; pp, postpartum; PPD, postpartum depression; preg, pregnant; PRISM, PRogram In Support of Moms; psych, 
psychiatry/psychology; PWH, Partnership for Women’s Health model; RCT, randomized controlled trial; SW, social worker; USA, United States; 
VA, Veterans Affairs; wk, week; yr, year
*Quality scale rating based on modified Downs and Black criteria. Percentage quality score is total score divided by maximum score possible. 
Maximum score varies based on the eligible number of items on the rating scale according to study type.
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